M-Clarity™ Qualitätsstufe = MQ100
P0115-25MG
P0115-5MG
SIALP0115-25MGEA
437
EUR
InStock
SIALP0115-25MG
SIALP0115-5MG
Procaspase-3 Aktivator (PAC1, (4-Benzylpiperazino)essigsäure-(3-allyl-2-hydroxybenzyliden)hydrazid) ≥98% (durch HPLC), Sigma-Aldrich®
Procaspase-3 Aktivator (PAC1, (4-Benzylpiperazino)essigsäure-(3-allyl-2-hydroxybenzyliden)hydrazid)
PAC-1 is a caspase 3 activator.
Caspase activation is a key strategy in cancer therapy. Caspase 3 is a key executioner caspase and direct effector of apoptosis. Hallmark of many cancers is the circumvention of signal in the activation of executioner caspases and loss of apoptotic response. EC50 for caspase 3 activation = 0.33 μM and caspase 7= 4.5 μM. The IC50 for apoptosis induction = 0.92 μM. Elevated caspase 3 level in cancerous cell lines and tissues allows PAC-1 to selectively induce apoptosis in tissues.